Dexamethasone exposure in normal‐weight and obese hospitalized <scp>COVID</scp> ‐19 patients: An observational exploratory trial-Reference-Cited by-全球学者库

Dexamethasone exposure in normal‐weight and obese hospitalized COVID ‐19 patients: An observational exploratory trial

Published:2022-06-15 Issue:7 Volume:15 Page:1796-1804
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Abouir Kenza¹²^ORCID,Gosselin Pauline³,Guerrier Stéphane²⁴^ORCID,Daali Youssef¹²⁵⁶^ORCID,Desmeules Jules¹²⁵⁶^ORCID,Grosgurin Olivier³⁶,Reny Jean‐Luc³⁶^ORCID,Samer Caroline¹⁵⁶^ORCID,Calmy Alexandra⁶⁷^ORCID,Ing Lorenzini Kuntheavy Roseline¹⁶

Affiliation:

1. Division of Clinical Pharmacology and Toxicology, Department of Anesthesiology, Pharmacology, Intensive Care and Emergency Medicine Geneva University Hospitals Geneva Switzerland

2. School of Pharmaceutical Sciences University of Geneva Geneva Switzerland

3. Division of General Internal Medicine Geneva University Hospitals Geneva Switzerland

4. Geneva School of Economics and Management University of Geneva Geneva Switzerland

5. Swiss Centre for Applied Human Toxicology (SCAHT) Geneva Switzerland

6. Faculty of Medicine University of Geneva Geneva Switzerland

7. Division of Infectious Diseases Geneva University Hospitals Geneva Switzerland

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13297

Reference30 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Dexamethasone in Hospitalized Patients with Covid-19

3. World Health Organization (WHO).Corticosteroids for COVID‐19. Available from:https://www.who.int/publications/i/item/WHO‐2019‐nCoV‐Corticosteroids‐2020.1

4. Obesity in patients with COVID-19: a systematic review and meta-analysis

5. Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 ( Covid ‐19)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity and diabetes mellitus are associated with SARS-CoV-2 outcomes without influencing signature genes of extrapulmonary immune compartments at the RNA level;Heliyon;2024-01

2. Obesity is associated with poor outcomes of corticosteroid treatment in patients with primary immune thrombocytopenia;British Journal of Haematology;2023-07-24

3. Anti‐inflammatory effects of dexamethasone in COVID‐19 patients: Translational population PK/PD modeling and simulation;Clinical and Translational Science;2023-07-05

4. Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients;Hepatology Communications;2023-02-20

5. Pharmacokinetic/Pharmacodynamic Modeling of Dexamethasone Anti-Inflammatory and Immunomodulatory Effects in LPS-Challenged Rats: A Model for Cytokine Release Syndrome;Journal of Pharmacology and Experimental Therapeutics;2023-01-11